Positive HOOK3 immunostaining was seen in 5,636 of our 10,572 (53.3%) interpretable prostate cancers and was considered low in 36.4% (Fig 1b) and high in 16.9% of cancers (Fig 1c). The gene discussed is HOOK3; the disease is prostate cancer.